No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Corvus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Corvus Wins New Buy From H.C. Wainwright Despite Recent Selloff
H.C. Wainwright Initiates Corvus Pharmaceuticals(CRVS.US) With Buy Rating
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Corvus Pharma Analyst Ratings
Citi Initiates Corvus Pharmaceuticals(CRVS.US) With Buy Rating, Announces Target Price $11